Medscape is available in 5 Language Editions – Choose your Edition here.


Posttraumatic Epilepsy Treatment & Management

  • Author: David Y Ko, MD; Chief Editor: Selim R Benbadis, MD  more...
Updated: Apr 04, 2014

Approach Considerations

Early posttraumatic seizure (PTS) should be treated promptly, as seizure activity is likely to further damage the already-compromised brain. For active seizures, IV phenytoin and sodium valproate are the antiepileptic drugs (AEDs) of choice and are usually effective in stopping the seizure, along with IV benzodiazepine.

With late PTS, treatment is not mandatory. Some patients isolated of seizure may choose not to take regular medication; in any case, compliance with long-term treatment is often poor in this group of patients. With PTE, patients should be on seizure medications. Surgical treatment is an option for PTE refractory to medication.

Treatment of posttraumatic epilepsy (PTE) does not require hospitalization. Admission may be needed for the treatment of status epilepticus or for video-EEG telemetry to assist in the diagnosis.

Go to Epilepsy and Seizures for an overview of this topic.


Anticonvulsant Therapy

Any anticonvulsant, except ethosuximide can be prescribed for PTE. To the authors' knowledge, no randomized controlled studies have been performed to prove that one AED is better than another in PTE. Some authors also recommend phenytoin,[12] but it seems to increase the risk of impairing cognitive function. Newer AEDS—particularly, topiramate and levetiracetam—are showing promise in this regard.[13, 14] . An AED that also may be useful for some of the symptoms of TBI such as headaches, anxiety can be taken into consideration when selecting AED.

Go to Antiepileptic Drugs for complete information on this topic.


Surgical Care

Surgical treatment of PTE, as in other types of epilepsy, has the goal of excision of the epileptogenic focus. Precise identification and excision of the focus is can be more difficult in PTE in other types of epilepsy, depending on the severity and location of TBI.

Go to Epilepsy Surgery for complete information on this topic.


Prevention of Posttraumatic Epilepsy

Prevention of PTE starts with prevention of head trauma. Clinicians should encourage preventive strategies, such as use of child seats and the use of helmets when cycling. Sports head injury guidlines should be followed to prevent recurrent head injury.

A guideline from the American Academy of Neurology notes that in adult patients with severe traumatic brain injury, prophylaxis with phenytoin is effective in decreasing the risk of early PTS; however, AED prophylaxis is probably not effective in decreasing the risk of late PTS (ie, PTS occurring beyond 7 days after injury).[15] Long-term AED treatment should be considered only after a diagnosis of PTE has been made.[16]

Similarly, a 2001 Cochrane Review concluded that although prophylactic use of AEDs soon after head injury reduces early seizures, there is no evidence that it reduces late seizures or has any effect on death or neurological disability.[17]

A study of seizure prophylaxis in patients with severe traumatic brain injury or subarachnoid hemorrhage found that intravenous levetiracetam appeared to be an alternative to fosphenytoin in that setting.[18] Ongoing clinical trials are addressing the antiepileptogenic potential of topiramate and levetiracetam in patients with traumatic brain injury.[13]

Administration of AEDs for the first week after neurosurgery is a routine practice.[19] Phenytoin has most often been used for this purpose, but levetiracetam is gaining popularity; it appears to be as effective, with fewer adverse effects.[20]

Some have proposed the existence of a window of opportunity of about 1 hour after traumatic brain injury. During this period, treatment with an AED (eg, sodium valproate) may prevent or abort the epileptogenic process.[21] Studies to explore such treatment are under way.

Some natural antioxidants, such as alpha-tocopherol and condensed tannins, have been demonstrated to be prophylactic for the occurrence of epileptic discharge in the iron-injected animal brain.[22]



Consult a neurologist to confirm the diagnosis. Consult with a psychiatrist if patient has nonepileptic seizures. Consultation with an epileptologist and neuropsychologist should be a part of the workup if surgery is considered.


Long-Term Monitoring

Regular follow-up should be performed for a review of seizure frequency and medications; for neuropsychological assessment; and for monitoring of adverse effects, drug levels if indicated, and the patient's neurologic status.

The Vietnam Head Injury Study (VHIS) followed more than 1,200 Vietnam veterans over a 30-year period who sustained mostly penetrating head injuries. The VHIS concluded that patients with penetrating head injuries carry a high risk of PTE decades after their injury. Predictors of PTE include lesion location (particularly if the location includes the left parietal lobe), lesion size, lesion type, and retained ferric metal fragments. Those patients will require long-term medical follow-up.[9]

Contributor Information and Disclosures

David Y Ko, MD Associate Professor of Clinical Neurology, Associate Director, USC Adult Epilepsy Program, Keck School of Medicine of the University of Southern California

David Y Ko, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Headache Society, American Clinical Neurophysiology Society

Disclosure: Received honoraria from UCB for speaking and teaching; Received consulting fee from Lundbeck for consulting; Received consulting fee from Westward for consulting; Received consulting fee from Esai for consulting; Received consulting fee from Supernus for consulting; Received consulting fee from Sunovion for speaking and teaching.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Jose E Cavazos, MD, PhD, FAAN, FANA, FACNS Professor with Tenure, Departments of Neurology, Pharmacology, and Physiology, Assistant Dean for the MD/PhD Program, Program Director of the Clinical Neurophysiology Fellowship, University of Texas School of Medicine at San Antonio; Co-Director, South Texas Comprehensive Epilepsy Center, University Hospital System; Director, San Antonio Veterans Affairs Epilepsy Center of Excellence and Neurodiagnostic Centers, Audie L Murphy Veterans Affairs Medical Center

Jose E Cavazos, MD, PhD, FAAN, FANA, FACNS is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Neurological Association, Society for Neuroscience, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Brain Sentinel, consultant.<br/>Stakeholder (<5%), Co-founder for: Brain Sentinel.

Chief Editor

Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cyberonics; Eisai; Lundbeck; Sunovion; UCB; Upsher-Smith<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cyberonics; Eisai; Glaxo Smith Kline; Lundbeck; Sunovion; UCB<br/>Received research grant from: Cyberonics; Lundbeck; Sepracor; Sunovion; UCB; Upsher-Smith.


Nicholas Lorenzo, MD, CPE Chairman and CEO, Neurology Specialists and Consultants; Senior Vice President, Founding Executive Director, Continuing Medical Education, Gannett Education (Division Gannett Healthcare Group)

Nicholas Lorenzo, MD, CPE is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, and American College of Physician Executives

Disclosure: Nothing to disclose.

Ewa Posner, MD, MRCP Consultant Pediatrician, Department of Pediatrics, University Hospital of North Durham, UK

Ewa Posner, MD, MRCP is a member of the following medical societies: European Paediatric Neurology Society and Royal College of Paediatrics and Child Health

Disclosure: Nothing to disclose.

  1. Hunt RF, Boychuk JA, Smith BN. Neural circuit mechanisms of post-traumatic epilepsy. Front Cell Neurosci. 2013. 7:89. [Medline]. [Full Text].

  2. Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia. 2003. 44 Suppl 10:11-7. [Medline].

  3. D'Ambrosio R, Perucca E. Epilepsy after head injury. Curr Opin Neurol. 2004 Dec. 17(6):731-5. [Medline].

  4. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol. 2003 Jun. 60(6):818-22. [Medline].

  5. Anderson GD, Temkin NR, Dikmen SS, Diaz-Arrastia R, Machamer JE, Farhrenbruch C. Haptoglobin phenotype and apolipoprotein E polymorphism: relationship to posttraumatic seizures and neuropsychological functioning after traumatic brain injury. Epilepsy Behav. 2009 Nov. 16(3):501-6. [Medline].

  6. Chamelian L, Reis M, Feinstein A. Six-month recovery from mild to moderate Traumatic Brain Injury: the role of APOE-epsilon4 allele. Brain. 2004 Dec. 127:2621-8. [Medline].

  7. Annegers JF, Hauser WA, Coan SP, et al. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998 Jan 1. 338(1):20-4. [Medline].

  8. Angeleri F, Majkowski J, Cacchio G, et al. Posttraumatic epilepsy risk factors: one-year prospective study after head injury. Epilepsia. 1999 Sep. 40(9):1222-30. [Medline].

  9. Raymont V, Salazar AM, Lipsky R, Goldman D, Tasick G, Grafman J. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology. 2010 Jul 20. 75(3):224-9. [Medline]. [Full Text].

  10. Skandsen T, Ivar Lund T, Fredriksli O, Vik A. Global outcome, productivity and epilepsy 3--8 years after severe head injury. The impact of injury severity. Clin Rehabil. 2008 Jul. 22(7):653-62. [Medline].

  11. Hudak AM, Trivedi K, Harper CR, Booker K, Caesar RR, Agostini M, et al. Evaluation of seizure-like episodes in survivors of moderate and severe traumatic brain injury. J Head Trauma Rehabil. 2004 Jul-Aug. 19(4):290-5. [Medline].

  12. Temkin NR, Dikmen SS, Wilensky AJ. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990 Aug 23. 323(8):497-502. [Medline].

  13. Löscher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev. 2010 Dec. 62(4):668-700. [Medline]. [Full Text].

  14. Pearl PL, McCarter R, McGavin CL, Yu Y, Sandoval F, Trzcinski S, et al. Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy. Epilepsia. 2013 Jul 22. [Medline].

  15. [Guideline] Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003 Jan 14. 60(1):10-6. [Medline].

  16. Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia. 2003. 44 Suppl 10:21-6. [Medline].

  17. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev. 2001. CD000173. [Medline].

  18. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010 Apr. 12(2):165-72. [Medline].

  19. Temkin NR. Prophylactic Anticonvulsants After Neurosurgery. Epilepsy Curr. 2002 Jul. 2(4):105-107. [Medline].

  20. Milligan TA, Hurwitz S, Bromfield EB. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology. 2008 Aug 26. 71(9):665-9. [Medline].

  21. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg. 1999 Oct. 91(4):593-600. [Medline].

  22. Mori A, Yokoi I, Noda Y, Willmore LJ. Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med Okayama. 2004 Jun. 58(3):111-8. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.